Karabay Ezgi Aktas, Izci Neslihan Fisek
Department of Dermatology and Venereology, Bahcesehir University Faculty of Medicine, Istanbul, Turkey.
Sisli Etfal Hastan Tip Bul. 2020 May 18;54(2):193-196. doi: 10.14744/SEMB.2018.46548. eCollection 2020.
To investigate the efficacy of erbium-doped yttrium aluminium garnet (Er:YAG) laser in the treatment of solar lentigines.
A retrospective study was conducted on patients treated with the only Er:YAG laser. In this study, 14 patients with multiple solar lentigines before treatment were included. Treatment parameters and all side effects were recorded. One independent, blinded dermatologist evaluated the clinical improvement and the patients also scored their satisfaction degree with the treatment.
The mean age of the patients was 41.07±7.16 years. The number of mean treatment session for each patient was 1.79±1.05. At the final visit, excellent improvement (76-100% clearance) was reached in eight (57.1%) patients, while good improvement (51-75% clearance) was achieved in five (35.7%) patients. Ten patients (71.4%) were very satisfied and four (28.5%) patients were satisfied with the results of the treatment. No side effects occurred.
Er:YAG laser treatment may be an effective and safe optional modality for solar lentigines.
探讨掺铒钇铝石榴石(Er:YAG)激光治疗日光性雀斑样痣的疗效。
对仅接受Er:YAG激光治疗的患者进行回顾性研究。本研究纳入14例治疗前有多发日光性雀斑样痣的患者。记录治疗参数及所有副作用。由一名独立的、不知情的皮肤科医生评估临床改善情况,患者也对治疗的满意度进行评分。
患者的平均年龄为41.07±7.16岁。每位患者的平均治疗次数为1.79±1.05次。在最后一次随访时,8例(57.1%)患者达到极佳改善(清除率76 - 100%),5例(35.7%)患者达到良好改善(清除率51 - 75%)。10例(71.4%)患者非常满意,4例(28.5%)患者对治疗结果满意。未发生副作用。
Er:YAG激光治疗可能是日光性雀斑样痣一种有效且安全的可选治疗方式。